Skip to content

More than a decade of peer-reviewed evidence.

A continuous clinical research program validating Cardio Explorer®.

The studies

Validated across the cardiovascular risk spectrum

Cardio Explorer® was developed, refined, and validated through retrospective diagnostic accuracy studies spanning algorithm development, model lock, and intended-use validation. A prospective implementation study is now evaluating clinical adoption, usability, and impact on patient management in routine care.

Obstructive CAD

Anatomical endpoint
University Hospital Basel
Study 01 · Basel I

Diagnostic Accuracy Study 

Initial algorithm development and internal validation

First feasibility cohort: machine-learned pattern recognition trained on patients referred for invasive coronary angiography.

LURIC Study
Study 02 · LURIC

Diagnostic Accuracy Study

Algorithm refinement and lock in a high-risk population

Locked model evaluated on independent validation sets within a high cardiovascular-risk cohort.

Maastricht University
Study 03 · Maastricht

Diagnostic Accuracy Study

Pivotal evaluation in the intended-use population

Validated in the intended-use population: low-to-intermediate-risk outpatients referred for CAD workup.

iGES
Study 04 · AOK Niedersachsen

Clinical Utility Study

Prospective implementation in primary care

Multicentre controlled study evaluating Cardio Explorer® acceptance, usability, and impact on diagnostic pathways in general practice.

Myocardial ischemia

Functional endpoint
University Hospital Basel
Study 05 · Basel II

Diagnostic Accuracy Study

Validation of the algorithm for ischemia prediction

Prospective single-centre cohort validating the memetic pattern-based algorithm (MPA) against Rubidium-82 PET myocardial perfusion imaging.

Study design
  • Design
    Prospective single-centre cohort; validation of the memetic pattern-based algorithm (MPA) for ischemia prediction
  • Population
    Consecutive patients referred for Rubidium-82 PET myocardial perfusion imaging (ischemia work-up for suspected/known CAD)
  • n (validation)
    2,417
  • Setting
    Tertiary centre, University Hospital Basel, Switzerland (Jul 2018 – Feb 2022)
  • Reference standard
    Rubidium-82 PET myocardial perfusion imaging (rest / pharmacologic stress with adenosine or regadenoson)
  • Ischemia definition
    Summed difference score (SDS) ≥ 2
Results

Consistent diagnostic performance across populations

Diagnostic performance was evaluated on the independent validation subsets of Basel and LURIC and on the full Maastricht cohort. Higher AUC means better discrimination between patients with and without obstructive CAD.

0.50
chance
0.75
1.00
perfect
Basel
n = 128
0.835
LURIC
n = 494
0.875
Maastricht
n = 696
0.878
AUC: area under the ROC curve; 0.50 = no better than chance, 1.00 = perfect discrimination.Reference standard: invasive coronary angiography / CCTA.
Publications

Scientific evidence behind Cardio Explorer®

Organised by evidence type to show the breadth and maturity of the science behind the Memetic Pattern Algorithm and the Cardio Explorer® platform: from the original 2014 methodology paper to current ESC-level comparative evaluations. Within each category, sorted newest to oldest.

Peer-reviewed publications

5 entries

Independent and collaborative research published in peer-reviewed journals.

  • Authors
    Remppis A, et al.
    DOI
    10.1007/s00399-025-01094-6
    View publication
    Abstract

    Despite extensive guideline coverage and broad access to cardiovascular diagnostics, Germany continues to observe substantial rates of missed and late-diagnosed coronary artery disease — the so-called German paradox. This article reviews the structural drivers of that gap and introduces Cardio Explorer® as a clinically deployable AI decision-support tool that combines clinical, laboratory, and demographic variables into a single probabilistic estimate of obstructive CAD. The paper details the Memetic Pattern Algorithm architecture, summarises validation across the Basel, LURIC and Maastricht cohorts, and discusses integration into ambulatory cardiology pathways.

  • Authors
    Bahir L, et al.
    DOI
    10.1007/s13167-023-00341-5
    View publication
    Abstract

    This peer-reviewed study evaluates whether AI-guided pretest probability assessment with Cardio Explorer® adds incremental diagnostic value on top of Rubidium-82 PET/CT myocardial perfusion imaging in patients with suspected coronary artery disease. Integrating the Cardio Explorer® probability estimate improved the prediction of haemodynamically relevant ischemia compared to imaging or clinical scoring alone and reduced equivocal interpretations, supporting a combined clinical-AI plus imaging workflow within the framework of Predictive, Preventive and Personalised Medicine (PPPM).

  • Authors
    Eurlings C, et al.
    View publication
    Abstract

    Objective: To evaluate the diagnostic performance of an artificial intelligence (AI) model — Cardio Explorer® — to assess the probability of obstructive coronary artery disease (CAD) in a low- to intermediate-risk outpatient population, using only clinical and laboratory variables already available at the point of care. Design: Retrospective diagnostic accuracy study using prospectively collected charts from an outpatient cardiology clinic at Maastricht University Medical Centre (MUMC+). Reference standard combined invasive coronary angiography, coronary CT angiography, and ≥3 years event-free follow-up. Results: The locked algorithm achieved an AUC of 0.878 with high sensitivity and a strong negative predictive value, supporting its use as a non-invasive rule-out tool in the intended-use population.

  • Authors
    Zellweger MJ, et al.
    DOI
    10.1007/s13167-018-0142-x
    View publication
    Abstract

    This paper situates Cardio Explorer® within the framework of Predictive, Preventive and Personalized Medicine (PPPM). It describes how a Memetic Pattern Algorithm trained and validated across independent European cohorts can support individualised CAD risk estimation without exposing patients to additional radiation, contrast, or stress testing. The article details the inputs, outputs, intended clinical use and the regulatory positioning of the tool, and outlines how AI-based pre-test probability can be integrated into shared decision-making for downstream imaging or invasive evaluation.

  • Authors
    Zellweger MJ, Brinkert M, Bucher U, Tsirkin A, Ruff P, Pfisterer ME.
    DOI
    10.1016/j.ijcard.2014.03.184
    View publication
    Abstract

    This foundational paper introduces a memetic pattern based algorithm (MPA) for the non-invasive diagnosis and exclusion of coronary artery disease. Using clinical, demographic, and laboratory inputs, the algorithm reconstructs patient-specific risk patterns and benchmarks them against a reference library of phenotypes with known coronary status. Initial evaluation in a Basel high-prevalence cohort referred for invasive coronary angiography demonstrated the feasibility of using machine-learned pattern recognition as a triage step prior to invasive testing, establishing the methodological foundation for the Cardio Explorer® platform.

Conference abstracts

1 entry

Presentations and abstracts from international cardiology congresses.

  • Authors
    Büsser AJ, et al.
    View abstract
    Abstract

    This ESC AI Congress abstract compares the third-generation Memetic Pattern Algorithm (MPA v3) — the engine behind Cardio Explorer® — to the ESC 2024 RF-CL (Risk Factor weighted Clinical Likelihood) algorithm for the estimation of obstructive coronary artery disease. Using a contemporary outpatient cohort, the analysis evaluates discrimination, calibration, and net reclassification across pre-test probability strata, with a particular focus on the low-to-intermediate risk band where guideline pathways most often produce ambiguous recommendations. MPA v3 demonstrates improved discrimination and a more favourable rule-out profile than RF-CL while preserving sensitivity, supporting its role as a non-invasive triage tool prior to advanced imaging.

Clinical trial registrations

1 entry

Registered prospective studies evaluating Cardio Explorer® in clinical practice.

  • Abstract

    Registered clinical study describing the prospective implementation of the Cardio Explorer® AI algorithm in routine outpatient cardiology practice. The protocol assesses real-world diagnostic performance, downstream resource utilisation, and impact on clinical decision-making versus standard guideline-based pathways.